Lloyds Luxuries Fund Raise of ₹24 Cr

Lloyds Luxuries Board Meeting Date

Lloyds Luxuries has intimated a board meeting on 04-Nov-2026 to consider half-yearly unaudited financial results for September 2026. No decisions have been taken yet.

Lloyds Luxuries Legal & Regulatory

Lloyds Luxuries disclosed a consumer complaint filed at Pune Commission regarding Truefitt & Hill membership. The claim seeks ₹4.36 lakh in refund, compensation, and costs.

Value

₹0.04 Cr

Lloyds Luxuries Employee Stock Options

Lloyds Luxuries NRC approved allotment of 18,912 ESOP Trust shares at ₹15 per share under its 2023 ESOP Scheme. Total paid-up capital increases to ₹24.15 Crore.

Lloyds Luxuries Annual General Meeting

Lloyds Luxuries Limited held its 13th Annual General Meeting on 31st August, 2026. The meeting covered financial performance, agenda items, and shareholder voting procedures.

Lloyds Luxuries Legal & Regulatory

Lloyds Luxuries Limited received a court summons from the ACJM-I Court, Gautam Buddh Nagar, concerning proceedings under the Legal Metrology Act. No financial impact is currently quantified.

Lloyds Luxuries Annual Report

Lloyds Luxuries Limited has submitted its 13th Annual Report for the Financial Year 2025-26. The filing includes the Notice of the Annual General Meeting and statutory reports.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.